Compounds > 4,4'-bis(2-di(2-hydroxyethyl)amino-4-(3-sulphophenylamino)-1,3,5-triazine-6-ylamino)stilbene-2,2'-disulphonic acid
Page last updated: 2024-12-08

4,4'-bis(2-di(2-hydroxyethyl)amino-4-(3-sulphophenylamino)-1,3,5-triazine-6-ylamino)stilbene-2,2'-disulphonic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,5-bis(5-tert-butylbenzoxazol-2-yl)thiophene: a fluorescent brightener, as well as a photoinitiator of polymerization; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID292429
SCHEMBL ID264177
MeSH IDM0162760

Synonyms (92)

Synonym
BIDD:GT0727
benzoxazole, 2,2'-(2,5-thiophenediyl)bis[5-(1,1-dimethylethyl)-
einecs 230-426-4
2,5-thiophenediylbis(5-tert-butyl-1,3-benzoxazole)
benzoxazole, 2,2'-(2,5-thiophenediyl)bis(5-tert-butyl-
2,2'-(2,5-thiophenediyl)bis(5-tert-butylbenzoxazole)
2,5-bis(5-tert-butylbenzoxazol-2-yl)thiophene
bbot 150
benzoxazole, 2,2'-(2,5-thiophenediyl)bis(5-(1,1-dimethylethyl)-
nsc 158163
uvitex ob
CBDIVE_008000
2,5-thiophenediyl)bis[5-tert-butylbenzoxazole]
2,5-bis(5'-tert-butyl-2-benzoxazolyl)thiophene
benzoxazole,2'-(2,5-thiophenediyl)bis[5-(1,1-dimethylethyl)-
nsc-158163
bbot
benzoxazole,2'-(2,5-thiophenediyl)bis[5-tert-butyl-
7128-64-5
2,5-bis(5-tert-butyl-2-benzoxazolyl)thiophene
nsc158163
2,5-bis(5-tert-butyl-benzoxazol-2-yl)thiophene, suitable for scintillation, 99%
STK386365
2,2'-thiene-2,5-diylbis(5-tert-butyl-1,3-benzoxazole)
AC-10399
B1554
2,5-bis(5-tert-butylbenzo[d]oxazol-2-yl)thiophene
5-tert-butyl-2-[5-(5-tert-butyl-1,3-benzoxazol-2-yl)thiophen-2-yl]-1,3-benzoxazole
AKOS005221640
ec 230-426-4
bis(tert-butyl benzoxazolyl) thiophene
unii-w7ur9129gp
w7ur9129gp ,
FT-0610265
fluorescent brightener 362
4,4'-bis(2-di(2-hydroxyethyl)amino-4-(3-sulphophenylamino)-1,3,5-triazine-6-ylamino)stilbene-2,2'-disulphonic acid
c.i. fluorescent brightener 362
52232-33-4
uvitex 2b
2,5-bis(5-(tert-butyl)benzo[d]oxazol-2-yl)thiophene
tinopal ob
fluorescent brightener 184
brightener ob
c.i. fluorescent brightener 184benzoxazole
c.i. 515245
bis(t-butyl benzoxazolyl) thiophene
2,2'-(2,5-thiophenediyl)bis(5-(1,1-dimethylethyl))benzoxazole
2,5-di(5-tert-butylbenzoxazol-2-yl)thiophene
keyfluor white pl
benzoxazole, 2,2'-(2,5-thiophenediyl)bis(5-(1,1-dimethylethyl))-
bbot [mi]
uvitex 3bsa
ci 515245
c.i. fluorescent brightening agent 184
bis(t-butyl benzoxazolyl) thiophene [inci]
c26h26n2o2s
BP-30128
2,2'-(2,5-thiophenediyl)bis[5-tert-butylbenzoxazole]
SCHEMBL264177
DTXSID1048205
2,2'-(2,5-thiophenediyl)bis[5-(1,1-dimethylethyl)benzoxazole]
12224-40-7
W-104527
2,5-bis-(5-tert-butyl-2-benzoxazolyl)thiophene
2,5-bis(5-t-butylbenzoxazol-2-yl)thiophene
2,5-bis-2(5-tert-butylbenzoxazolyl)thiophene
2,5-bis(5-tert-butylbenzoxazoyl)-2-thiophene
5-tert-butyl-2-[5-(5-tert-butyl-1,3-benzoxazol-2-yl)-2-thienyl]-1,3-benzoxazole #
B4221
2,5-bis-(5-tert-butyl-2-benzoxazol-2-yl)thiophene
mfcd00005774
2,5-bis(5-tertbutyl-2-benzoxazolyl)thiophene
2,5-bis(5-tert-butyl-benzoxazol-2-yl)thiophene
BCP25296
SY048602
2,5-bis(5-t-butyl-benzoxazol-2-yl)thiophene
2,2'-(2,5-thienediyl)bis(5-tert-butyl-1,3-benzoxazole)
Q26840908
2,5-bis(5-tert-butyl-2-benzoxazolyl)thiophene (purified by sublimation)
AS-14172
bbot;ob-fba 184
AMY23194
AC7899
2,5-bis[5-(tert-butyl)-1,3-benzoxazol-2-yl]thiophene
2,5-bis(5-tert-butyl-benzoxazol-2-yl)thiophene (bbot)
A934173
2,5-bis(5-tert-butylbenzooxazol-2-yl)thiophene
2,5-bis(5-(tert-butyl)benzo-[d]oxazol-2-yl)thiophene
CS-0168851
2,5-bis(5-tert-butyl-2-benzoxazolyl)thiophene(purifiedbysublimation)
optical brightener ob (fba 184)
CS-0010140
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (20.00)18.7374
1990's2 (20.00)18.2507
2000's3 (30.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.10 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (9.09%)4.05%
Observational0 (0.00%)0.25%
Other10 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
thiophenes
Thiophenes: A monocyclic heteroarene furan in which the oxygen atom is replaced by a sulfur.. thiophenes : Compounds containing at least one thiophene ring.		2.1310mancude organic heteromonocyclic parent;
monocyclic heteroarene;
thiophenes;
volatile organic compound		non-polar solvent
benzoxazoles
1,3-benzoxazole : A benzoxazole in which the benzene ring is fused to a 1,3-oxazole ring across positions 4 and 5.. benzoxazole : Compounds based on a fused 1,2- or 1,3-oxazole and benzene bicyclic ring skeleton.		2.13101,3-benzoxazoles;
mancude organic heterobicyclic parent
eosine yellowish-(ys)
Eosine Yellowish-(YS): A versatile red dye used in cosmetics, pharmaceuticals, textiles, etc., and as tissue stain, vital stain, and counterstain with HEMATOXYLIN. It is also used in special culture media.. eosin YS dye : An organic sodium salt that is 2',4',5',7'-tetrabromofluorescein in which the carboxy group and the phenolic hydroxy group have been deprotonated and the resulting charge is neutralised by two sodium ions.		1.9910organic sodium salt;
organobromine compound		fluorochrome;
histological dye
chromotrope 2r
chromotrope 2R: RN given refers to disodium salt. acid red 29 : An organic sodium salt that is the disodium salt of 4,5-dihydroxy-3-(phenyldiazenyl)naphthalene-2,7-disulfonic acid. It is used as the plasma stain in trichrome techniques.		2.0510organic sodium salthistological dye
delphinidin
Paraffin: A mixture of solid hydrocarbons obtained from petroleum. It has a wide range of uses including as a stiffening agent in ointments, as a lubricant, and as a topical anti-inflammatory. It is also commonly used as an embedding material in histology.. delphinidin chloride : An anthocyanidin chloride that has delphinidin as the cationic counterpart.		1.9710anthocyanidin chloride
deoxyglucose
Deoxyglucose: 2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity.. deoxyglucose : A deoxyhexose comprising glucose having at least one hydroxy group replaced by hydrogen.		2.0210
stilbenes
Stilbenes: Organic compounds that contain 1,2-diphenylethylene as a functional group.. trans-stilbene : The trans-isomer of stilbene.		1.9710stilbene
c.i. fluorescent brightening agent 28
4,4'-bis({4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl}amino)stilbene-2,2'-disulfonic acid : An organosulfonic acid comprising stilbene having 4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl}amino groups at the 4 and 4'-positions and sulfo groups at the 2- and 2'-positions.		2.7330
eosine i bluish
Eosine I Bluish: A red fluorescein dye used as a histologic stain. It may be cytotoxic, mutagenic, and inhibit certain mitochondrial functions.		2.0210organic sodium saltfluorescent dye;
histological dye
aniline blue
aniline blue: fluorochrom widely used by botanists		2.0210
direct black 3
[no description available]		2.0210
ConditionIndicatedRelationship StrengthStudiesTrials
Infections, Microspora
[description not available]		03.1450
Diarrhea
An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.		02.5120
Intestinal Diseases, Parasitic
Infections of the INTESTINES with PARASITES, commonly involving PARASITIC WORMS. Infections with roundworms (NEMATODE INFECTIONS) and tapeworms (CESTODE INFECTIONS) are also known as HELMINTHIASIS.		02.730
AIDS-Related Opportunistic Infections
Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.		02.730
Sensitivity and Specificity
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)		02.4220
HIV Coinfection
[description not available]		02.0610
HIV Infections
Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).		02.0610
Fish Diseases
Diseases of freshwater, marine, hatchery or aquarium fish. This term includes diseases of both teleosts (true fish) and elasmobranchs (sharks, rays and skates).		02.0210
Isospora Infection
[description not available]		01.9910
Disease, Pulmonary
[description not available]		01.9710
Fungal Diseases
[description not available]		01.9710
Kidney Diseases
Pathological processes of the KIDNEY or its component tissues.		01.9710
Lung Diseases
Pathological processes involving any part of the LUNG.		01.9710
Mycoses
Diseases caused by FUNGI.		01.9710